Ganie, Mohd Ashraf <br/><br/>
Improved efficacy of low-dose spironolactone and metformin combination than either drug alone in the management of women with polycystic ovary syndrome (PCOS): a six-month, open-label randomized study.  [electronic resource] 

 -  The Journal of clinical endocrinology and metabolism  Sep 2013 
 - 3599-607 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1945-7197 
<br/><br/><label>Standard No.: </label>10.1210/jc.2013-1040  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Blood Glucose<br/>Blood Pressure--drug effects<br/>Body Composition--drug effects<br/>Body Mass Index<br/>Drug Therapy, Combination<br/>Female<br/>Follicle Stimulating Hormone--blood<br/>Humans<br/>Hypoglycemic Agents--administration & dosage<br/>Insulin--blood<br/>Insulin Resistance<br/>Luteinizing Hormone--blood<br/>Menstrual Cycle--drug effects<br/>Metformin--administration & dosage<br/>Mineralocorticoid Receptor Antagonists--administration & dosage<br/>Polycystic Ovary Syndrome--blood<br/>Spironolactone--administration & dosage<br/>Testosterone--blood<br/>Treatment Outcome<br/>Waist-Hip Ratio